Deerfield Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Deerfield Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,601,427	Closed	-$54.1M	–	171
2021 Q2	$54.1M	Sell	1,601,427 -107,530	-6%	-$2.74M	0.96%	28
2021 Q1	$40M	Buy	1,708,957 +250,000	+17%	+$7.57M	0.84%	42
2020 Q4	$42M	Buy	1,458,957 +453,470	+45%	+$11.4M	0.83%	36
2020 Q3	$20.4M	Buy	1,005,487 +131,597	+15%	+$3.21M	0.5%	64
2020 Q2	$26.3M	Sell	873,890 -80,210	-8%	-$2.89M	0.76%	41
2020 Q1	$30M	Buy	954,100 +404,100	+73%	+$14M	0.95%	34
2019 Q4	$25.9M	Buy	550,000 +526,400	+2,231%	+$15.2M	0.83%	39
2019 Q3	$152K	Sell	23,600 -160,000	-87%	-$1.34M	0.01%	95
2019 Q2	$2.25M	Sell	183,600 -69,800	-28%	-$777K	0.08%	90
2019 Q1	$3.43M	Sell	253,400 -382,443	-60%	-$3.43M	0.13%	80
2018 Q4	$2.55M	Hold	635,843	–	–	0.1%	85
2018 Q3	$4.28M	Buy	+635,843	New	+$6.06M	0.15%	88

Deerfield Management's CNST Position: Q3 2021 in Review

Deerfield Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,601,427 shares — an estimated $54.1M sold.

Deerfield Management first reported a position in CNST in Q3 2018 and held it in 12 quarters. The position peaked at $54.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Deerfield Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Deerfield Management sold 1,601,427 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $54.1M.
Deerfield Management first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 12 quarters.
Deerfield Management's Constellation Pharmaceuticals, Inc. position peaked at $54.1M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Deerfield Management's 13F filing for Q3 2021, filed 15 Nov 2021.